Realcan Pharmaceutical Group Co., Ltd. at its Annual General Meeting of 2022 held on 19 May 2023, approved the appointment of Zhang Shoukai, Li Zhe and Wu Liyan as Non-Independent Director, Liu Xijun, Wang Jifa and Sun Kaoxiang as Independent Director and Zhang Yan as Non-Employee Supervisor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.52 CNY | 0.00% | +2.86% | -22.94% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.94% | 523M | |
+17.35% | 71.39B | |
+2.39% | 25.1B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-3.38% | 3.93B | |
-2.61% | 3.86B |
- Stock Market
- Equities
- 002589 Stock
- News Realcan Pharmaceutical Group Co., Ltd.
- Realcan Pharmaceutical Group Co., Ltd. Approves the Executive Appointments